Jerry Tan, MD, is joining Derm-Biome Pharmaceuticals, Inc.’s Scientific Advisory Board.
Dr. Jerry Tan, is a dermatologist in Windsor, ON, the immediate past President of the Acne and Rosacea Society of Canada, co-chair of the Acne Core Outcomes Research Network (ACORN),
Derm-Biome Pharmaceuticals develops topical treatments for acne, atopic dermatitis, and precancerous skin conditions. The company has developed a natural product-based gel that rapidly targets different aspects of acne pathophysiology. Derm-Biome’s compound targets inflammation that leads to collagen degradation and stimulates collagen synthesis to help address acne scars.
“Acne is a very common skin disease, but there is still a real unmet need for treatments that are both well-tolerated and effective. Acne scarring is a result of intense inflammation, damage to stem cells and a degradation of collagen, but current acne drugs typically do not feature a potent anti-inflammatory component. I am very happy to join the Derm-Biome team and excited over the prospects of the company advancing a much-needed treatment option for acne,” says Dr. Tan in a news release.
Derm-Biome CEO Gordon Eberwein adds, “We very much look forward to adding Dr. Jerry Tan and his vast knowledge to our team. The acne market is changing, as consumers seek safer and more natural topical alternatives that offer faster results with low irritation. We have developed a product that we feel can help address that changing market need.”
